| Price | 78.50p on 20-11-2025 at 16:40:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 80.00p |
| Sell | 77.00p |
| Last Trade: | Buy 3,952.00 at 78.60p |
| Day's Volume: | 2,082,888 |
| Last Close: | 78.50p |
| Open: | 80.00p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 78.00p - 80.00p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £340.43m |
| VWAP: | 78.72971p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 3,952 | 78.60p | Ordinary |
16:28:11 - 20-Nov-25 |
| Buy* | 2,500 | 78.9999p | Ordinary |
16:22:54 - 20-Nov-25 |
| Buy* | 6,533 | 80.00p | Ordinary |
16:20:39 - 20-Nov-25 |
| Sell* | 45,000 | 78.4555p | Ordinary |
16:20:15 - 20-Nov-25 |
| Buy* | 60,000 | 79.44p | Ordinary |
16:15:22 - 20-Nov-25 |
| Buy* | 1,896 | 78.8999p | Ordinary |
16:13:35 - 20-Nov-25 |
| Buy* | 25 | 78.9661p | Ordinary |
16:13:17 - 20-Nov-25 |
| Buy* | 24,045 | 78.97p | Ordinary |
16:04:58 - 20-Nov-25 |
| Buy* | 5,000 | 79.15p | Ordinary |
16:04:34 - 20-Nov-25 |
| Sell* | 45,000 | 78.3666p | Ordinary |
16:03:33 - 20-Nov-25 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
| 30th Sep 2025 7:00 am | RNS | Interim Half Year Results 2025 |
| 15th Sep 2025 7:00 am | RNS | Notice of Interim Results |
| 9th Sep 2025 7:00 am | RNS-R | Shortlisted for AIM Awards Technology of the Year |
